Nemucore Medical Innovations, Inc to Open Nanomedicine GMP Manufacturing and Development Facility in Worcester, Massachusetts

Share |

Nemucore Medical Innovations, Inc. (NMI) recently signed a lease with the Massachusetts Biomedical Initiatives (MBI) for research space in Worcester, Massachusetts where development of life-saving nanomedicines for the treatment of drug resistant can

Wellesley, MA (I-Newswire) November 30, 2010 - Nemucore Medical Innovations, Inc. (NMI), dedicated to the development and commercialization of life-saving nanomedicines for the treatment of drug resistant cancers, recently signed a lease with the Massachusetts Biomedical Initiatives (MBI) for space in Worcester, Massachusetts. The company will use the facility to conduct experimental research to scale-up for commercial production promising nanopharmaceuticals developed with research teams participating in Northeastern University’s Center of Cancer Nanotechnology Excellence (CCNE), and by other collaborators and partners. The MBI facility allows NMI to further its research until it moves into larger space in Worcester that will support a significant enhancement of nanomedicine cGMP manufacturing and research space for additional employees.

“This new laboratory and the future cGMP facility represent critical components of our strategy to facilitate the development of a quality system to manufacture nanomedicine products in compliance with FDA guidelines and speed the translation from the laboratory to clinical investigation. We are committed to growing Nemucore in Worcester, and contributing to the creation of the biotechnology workforce in the region” said Dr. Tim Coleman, NMI President and CEO.

Kevin O’Sullivan, President and CEO of MBI, stated “We are pleased to have Nemucore Medical Innovations join the growing tenant list in the MBI life science incubator facilities, and have been impressed by Nemucore’s commitment to growth in the Worcester region, and participation in the growth and expansion of biotechnology in Massachusetts.”





About Nemucore Medical Innovations:
Nemucore Medical Innovations, Inc. is dedicated to the development and commercialization of life-saving nanomedicines for the treatment of MDR cancers. We accomplish this objective by conceiving, testing and manufacturing nanomedicines, applying our proprietary nanoformulation technologies to drugs that need improved delivery solutions. NMI was founded in 2008 and is based in Worcester and Wellesley.

Company Contact Information
Nemucore Medical Innovations
AMBiernacki
33 Kirkland Circle
Wellesley, MA
02481
Phone : (617) 285-3561




Science and Research

biotech jobs   Nemucore Medical Innovations   Mass Biomedical Initiatives   research space   Worcester  

November 30, 2010

Content Disclaimer: If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service company and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter,make sure to check the official company website for accurate release dates as our site displays the date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.


Related Releases

Book Launch: Much-Anticipated Memoir of Geoffrey Notkin, Star of TV’s “Meteorite Men,” Out June 1
"Rock Star: Adventures of a Meteorite Man" Available NOW For Advanced Orders and Media Review Copies

20 High School Students to Participate in USA Biology Olympiad at Purdue University
The USA Biology Olympiad concentrates on stimulating young scholars’ intellectual curiosity and developing their critical thinking skills in biological reasoning, and culminates with the U.S. Team’s participation in the IBO.

Facebook Announces Tweaks on Policy Change
Facebook has announced another round of updates to previous drafts of its terms of service named Statements of Rights and Responsibilities in an attempt to ease concerns on information sharing and privacy.

Sound Mental Health Supported By The Science Of Dream Interpretation And Dream Therapy
ScientificDreamInterpretation.com is a website that tackles the scientific method of dream interpretation that is aimed at attaining good health, wisdom and happiness.

Faculty Of 1000 Launches A Revolutionary Article Search Engine: The F1000 SmartSearch
Faculty of 1000 (F1000) today announced the launch of a new intuitive PubMed search tool, the F1000 SmartSearch.


© Copyright 2012 I-Newswire.com - press release distribution service. All rights reserved